摘要
高迁移率族蛋白B1(HMGB1)由HMGB1基因编码产生,是广泛存在于细胞核内且高度保守的非组蛋白染色体结合蛋白,其在真核细胞DNA复制和修复中发挥重要作用.分泌或释放到胞外的HMGB1作为一种迟发型炎症介质,在脓毒血症、自身免疫性疾病、恶性肿瘤、肝脏相关疾病等方面介导炎症反应.近年来,对HMGB1基因多态性的研究为进一步明确疾病的发病机制提供了理论基础,由此可对疾病易患性进行早期预测,从而进行早期干预,为疾病的精准预防和治疗奠定基础.就其与临床疾病易感性和预后的相关性研究作一综述.
High mobility group protein B1 (HMGB1) is encoded by HMGB1 gene and is a highly conserved non-histone chromosomal binding protein widely present in the nucleus. It plays an important role in DNA replication and repair of eukaryotic cells. As a delayed inflammatory mediator, HMGB1 secreted or released extracellularly mediates inflammatory response in sepsis, autoimmune diseases, malignant tumors, liver-related diseases, and so on. In recent years, the studies of HMGB1 gene polymorphism have provided a theoretical basis for further clarifying the pathogenesis of diseases. These studies provided early predictions of disease susceptibility for early intervention and provided the basis for precise prevention and treatment of diseases. In this paper, the correlation between HMGB1 and clinical disease susceptibility and prognosis was reviewed.
作者
张静娇
邓春青
Zhang Jingjiao;Deng Chunqing(Department of Infection,the First Hospital of Shanxi Medical University,Taiyuan 030001,China)
出处
《国际生物医学工程杂志》
CAS
2019年第4期357-361,共5页
International Journal of Biomedical Engineering
基金
山西省卫生和计划生育委员会科研课题(2015028).
